4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-035687
Director acquired 3,860 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dunsire Deborah Director | 2023-06-07 | Grant or award | +3,860 | 19,730 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dunsire Deborah Director | 2023-06-07 | Grant or award · Stock Option (Right to Buy) | +7,110 | 7,110 | D: show line 2 in the form |
Loading xslF345X04/doc4.xml…